CTZ

Venture Capital Caesarea, Israel Est. 2014
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
across known amounts
Stages

About

CTZ is a private medical accelerator and incubator focused on medical devices. CTZ has access to a pipeline of Israeli innovations, medical device seed projects, and technologies based on its in-depth industry network. The accelerator provides seed funding, operational management, and supporting infrastructure for medical devices from seed stage to sales stage for developing, expanding, and commercializing successful enterprises.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is CTZ's primary focus as an investor?
CTZ is a private medical accelerator and incubator, primarily focused on medical devices. They provide seed funding, operational management, and supporting infrastructure for medical devices from seed stage to sales stage.
When was CTZ founded?
CTZ was founded in 2014.
Where is CTZ headquartered?
CTZ is headquartered in Caesarea, Israel, at Tarshish 5.
What kind of companies does CTZ typically support?
CTZ supports Israeli innovations, medical device seed projects, and technologies, leveraging its in-depth industry network.
Can you name some notable alumni companies from CTZ's accelerator program?
Notable alumni from CTZ's accelerator program include Orca Surgical, which focuses on solutions for refractive ophthalmologic surgery, and NONAGON, a virtual care solution.
What is the sector concentration of CTZ's alumni portfolio?
According to startupim data, all listed alumni companies, such as NONAGON, Orca Surgical, and RadSense, are concentrated in the 'Health Tech & Life Sciences' sector.
How many graduates has CTZ's accelerator program produced?
CTZ's accelerator program has produced 3 graduates.
Does CTZ take equity in the companies it supports through its accelerator?
No, CTZ's accelerator program does not take equity.